Skip to main content
HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.510
+0.120 (3.54%)
At close: Aug 13, 2025, 4:00 PM
3.530
+0.020 (0.57%)
Pre-market: Aug 14, 2025, 9:01 AM EDT

HeartSciences Revenue

In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%. HeartSciences had revenue of $4.35K in the quarter ending April 30, 2025.

Revenue (ttm)
$4.35K
Revenue Growth
-76.61%
P/S Ratio
1,836.70
Revenue / Employee
$290
Employees
15
Market Cap
7.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 20254.35K-14.25K-76.61%
Apr 30, 202418.60K13.45K261.17%
Apr 30, 20235.15K-9.22K-64.17%
Apr 30, 202214.37K-11.23K-43.86%
Apr 30, 202125.60K-38.58K-60.11%
Apr 30, 2020 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings

HSCS News

More News